cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Perrigo Company Public Limited Company
4 own
7 watching
Current Price
$31.5
$0.03
(0.1%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
4,443.11M
52-Week High
52-Week High
41.44000
52-Week Low
52-Week Low
30.78000
Average Volume
Average Volume
1.44M
Dividend Yield
Dividend Yield
0.02038
P/E Ratio
P/E Ratio
54.78
iconMarket Capitalization4,443.11M
icon52-Week High41.44000
icon52-Week Low30.78000
iconAverage Volume1.44M
iconDividend Yield0.02038
iconP/E Ratio54.78
What does the Perrigo Company Public Limited Company do?
Perrigo Company plc, together with its subsidiaries, develops, manufactures, markets, and distributes over-the-counter (OTC) consumer goods and pharmaceutical products worldwide. The company operates through Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences, and Other segments. The CHC segment offers OTC products in various categories, including analgesics, cough/cold/allergy/sinus, gastrointestinal, infant nutritional, smoking cessation, animal health, feminine hygiene, diabetes and dermatological care, diagnostic, scar management, and other healthcare products, as well as vitamins, minerals, and dietary supplements (VMS); and contract manufacturing services. It serves retail drug, supermarket, mass merchandise chains, and wholesalers through sales force and industry brokers. The BCH segment provides branded OTC products in the natural health and VMS; cough, cold, flu, and allergy; personal care and derma-therapeutics; lifestyle; pain relief, nasal decongestants, and cold sore management; and anti-parasite areas, as well as offers generic pharmaceutical products. It serves pharmacies, drug, and grocery stores through pharmacy sales force, as well as a network of pharmacists. The Rx segment offers generic and specialty pharmaceutical prescription drugs in various dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, women's health products, oral solid dosage forms, and oral liquid formulations; and ORx products. It serves wholesalers; retail drug, supermarket, and mass merchandise chains; hospitals; and pharmacies. The Specialty Sciences segment offers Tysabri to treat multiple sclerosis. The Other segment offers active pharmaceutical ingredients used by generic and branded pharmaceutical companies. The company was founded in 1887 and is headquartered in Dublin, Ireland.
Read More
How much money does Perrigo Company Public Limited Company make?
News & Events about Perrigo Company Public Limited Company.
Ticker Report
3 months ago
Perrigo Company plc (NYSE:PRGO Get Rating) Director Geoffrey M. Parker acquired 10,000 shares of the firms stock in a transaction on Tuesday, June 13th. The stock was purchased at an average price of $33.06 per share, for a total transaction of $330,600.00. Following the transaction, ...
PR Newswire
5 months ago
Perrigo to Release First Quarter 2023 Financial Results on May 9, 2023 Perrigo to Release First Quarter 2023 Financial Results on May 9, 2023 PR Newswire DUBLIN, April 25, 2023 DUBLIN, April 25, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care...
Ticker Report
5 months ago
StockNews.com lowered shares of Perrigo (NYSE:PRGO Get Rating) from a buy rating to a hold rating in a research note issued to investors on Saturday morning. PRGO has been the subject of several other reports. Raymond James raised their price target on shares of Perrigo from $42.00 to $43.00...
PR Newswire
5 months ago
Firefly Expands Its Commitment to Sustainability with Free Recycling Program Firefly Expands Its Commitment to Sustainability with Free Recycling Program PR Newswire CHICAGO, April 6, 2023 Brand Partners with TerraCycle to Offer Consumers Way to Recycle Product Waste CHICAGO, April 6, 2023...
PR Newswire
7 months ago
Perrigo Announces FDA Approval of the Store Brand OTC Equivalent of Advil Dual Action Tablets Perrigo Announces FDA Approval of the Store Brand OTC Equivalent of Advil Dual Action Tablets PR Newswire DUBLIN, March 1, 2023 DUBLIN, March 1, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a...
Frequently Asked Questions
Frequently Asked Questions
What is Perrigo Company Public Limited Company share price today?
plus_minus_icon
Can Indians buy Perrigo Company Public Limited Company shares?
plus_minus_icon
How can I buy Perrigo Company Public Limited Company shares from India?
plus_minus_icon
Can Fractional shares of Perrigo Company Public Limited Company be purchased?
plus_minus_icon
What are the documents required to start investing in Perrigo Company Public Limited Company stocks?
plus_minus_icon
What is today’s traded volume of Perrigo Company Public Limited Company?
plus_minus_icon
What is today’s market capitalisation of Perrigo Company Public Limited Company?
plus_minus_icon
What is the 52-Week High and Low Range of Perrigo Company Public Limited Company?
plus_minus_icon
What percentage is Perrigo Company Public Limited Company down from its 52-Week High?
plus_minus_icon
What percentage is Perrigo Company Public Limited Company up from its 52-Week Low?
plus_minus_icon
Current Price
$31.5
$0.03
(0.1%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
$47.12
$0.83 (1.80 %)
Novartis AG
Novartis AG
$100.26
$-1.16 (-1.14 %)
Mohawk Industries Inc.
Mohawk Industries Inc.
$83.92
$-0.93 (-1.10 %)
Horizon Therapeutics Public Ltd Co
Horizon Therapeutics Public Ltd Co
$115.72
$-0.02 (-0.02 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
$47.12
$0.83 (1.80 %)
Novartis AG
Novartis AG
$100.26
$-1.16 (-1.14 %)
Mohawk Industries Inc.
Mohawk Industries Inc.
$83.92
$-0.93 (-1.10 %)
Horizon Therapeutics Public Ltd Co
Horizon Therapeutics Public Ltd Co
$115.72
$-0.02 (-0.02 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00